CLINICAL_TRIALS
trial_result
· 2013-11-08
Clinical Trial Update: A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients [Phase 4]
Summary
A Phase 4 study evaluating adjunctive aripiprazole in schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED